Table 1

Participant’s characteristics

Characteristics (no. of respondents)Respondents (%)
Age, years (n=247)
Under 3011 (4.5)
30–40104 (42.1)
41–5064 (25.9)
51–6050 (20.2)
Over 6018 (7.3)
Gender (n=246)
Female158 (64.2)
Male88 (35.8)
Country* (n=245)
India30 (12.2)
Brazil26 (10.6)
USA23 (9.4)
Canada20 (8.2)
Mexico14 (5.7)
Australia13 (5.3)
UK12 (4.9)
Chile11 (4.5)
Italy8 (3.3)
Portugal7 (2.9)
Belgium7 (2.9)
Others†74 (30.2)
Consider themselves to be from minority racial/ethnic group (n=245)
Yes30 (12.2)
No215 (87.8)
Current clinical role (n=245)
Resident6 (2.4)
Primary care practitioner, pediatrician, family doctor,or internal medicine doctor11 (4.5)
Pediatric endocrinology fellow18 (7.3)
Pediatric endocrinologist/diabetologist154 (62.9)
Adult endocrinology fellow1 (0.4)
Adult endocrinologist/diabetologist24 (9.8)
Nurse practitioner/registered nurse24 (9.8)
Other (registered nutritionist, dietitian, nutritionist, diabetes educator, mental health professional)13 (5.3)
Years of practice (n=246)
Less than 342 (17.1)
3–537 (15)
5–1046 (18.7)
More than 10121 (49.2)
Main practice setting (n=245)
Private hospital/outpatient clinic56 (22.9)
Public or government hospital/outpatient clinic73 (29.8)
University or academic hospital/outpatient clinic104 (42.5)
Primary care center4 (1.6)
General practitioner office2 (0.8)
Other (diabetes association)6 (2.5)
Access to an endocrinologist/diabetologist as a consultant (n=247)
Yes56 (22.7)
No3 (1.2)
She/he is an endocrinologist/diabetologist188 (76.1)
Number of patients with T1D followed (n=247)
Less than 10071 (29.1)
100–20042 (16.9)
201–50059 (23.8)
More than 50075 (30.2)
Provision of universal healthcare insurance/coverage for the use of insulin pump and/or CGM systems in your country (n=247)
Yes65 (26.3)
No112 (45.3)
Partially70 (28.3)
Coverage/reimbursement of private insurance companies for insulin pump and/or CGM systems in your country (n=246)
Yes57 (23.2)
No132 (53.7)
Partially59 (24)
Member of the International Society for Pediatric and Adolescent Diabetes (n=247)
Yes173 (70)
No74 (30)
  • *Top 11 country.

  • †Countries with response: Argentina, Bangladesh, Bulgaria, Denmark, Ecuador, Egypt, Finland, Germany, Greece, Haiti, Indonesia, Ireland, Israel, Japan, Liberia, Luxembourg, Malaysia, Malta, Mauritius, Morocco, Myanmar, Netherlands, Norway, Pakistan, Paraguay, Peru, Poland, Republic of Korea, Romania, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Sweden, Thailand, Turkey and Uruguay.

  • CGM, continuous glucose monitoring; T1D, type 1 diabetes.